Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina

GMC Rosano, D Tousoulis, E McFadden… - International Journal of …, 2017 - Elsevier
Background Patients with microvascular angina (exertional angina, positive exercise tests
and normal coronary arteriograms) usually have a reduced coronary blood flow reserve …

Release of neuropeptide Y and hemodynamic changes during surgical removal of human pheochromocytomas

J Eurin, C Barthélemy, F Masson, G Maistre… - Regulatory peptides, 2000 - Elsevier
This study investigates the release of Neuropeptide Y from eight human
pheochromocytomas. Profil immunoreactive Neuropeptide Y (Ir-NPY) levels during the …

Relationships between plasma levels of catecholamines and neuropeptides and the survival time in patients with congestive heart failure

S Valdemarsson, A Bergdahl… - Journal of internal …, 1994 - Wiley Online Library
Objectives. To evaluate the importance of various variables reflecting neuroendocrine
activation in relation to prognosis in patients with congestive heart failure (CHF). Design …

Circulating neuropeptide Y in humans: relation to changes in catecholamine levels and changes in hemodynamics

GJ Hauser, MR Danchak, MP Colvin, RA Hopkins… - Neuropeptides, 1996 - Elsevier
Neuropeptide-Y (NPY) is a sympathetic cotransmitter, which causes vasoconstriction,
decreases coronary blood flow and decreases cardiac output. Circulating immunoreactive …

Neuropeptide Y and cardiovascular function

MJ Morris - Neuropeptide Y and related peptides, 2004 - Springer
Neuropeptide Y (NPY) is coreleased with the classical transmitter noradrenaline in both the
peripheral and central nervous systems, and has been shown to potentiate the pressor …